Company Encyclopedia
View More
name
SANAI HEALTH GP
01889.HK
Sanai Health Industry Group Company Limited, an investment holding company, engages in the manufacture, marketing, and sale of branded prescription and non-prescription drugs, and Chinese pharmaceutical products in the People’s Republic of China and Hong Kong. It operates through Pharmaceutical Products and Finance Leasing segments. The company is involved in the development, manufacture, marketing, and sale of pharmaceutical products; sale of pharmaceutical related software; and provision of consultancy services. It also provides finance leasing services; and engages in the research, production, and sale of health products, functional foods, and skincare products in the field of soft capsule dosage form.
1.450 T
01889.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
PharmaceuticalsIndustry
Industry Ranking38/48
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-10.53%D
    • Profit Margin-16.65%D
    • Gross Margin14.43%D
  • Growth ScoreC
    • Revenue YoY15.20%B
    • Net Profit YoY-222.23%E
    • Total Assets YoY1.66%C
    • Net Assets YoY-4.47%D
  • Cash ScoreC
    • Cash Flow Margin-600.44%E
    • OCF YoY15.20%B
  • Operating ScoreD
    • Turnover0.2D
  • Debt ScoreB
    • Gearing Ratio30.50%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Hong Kong Stock Movement: SANAI HEALTH GP rises 18%, no news support, capital flow attracts market attention?

    SANAI HEALTH GP rose 18.00%; CSPC Pharmaceutical Group rose 0.41%, with a transaction volume of HKD 828 million; China Biologic Products Holdings fell 0.29%, with a transaction volume of HKD 459 million; Hansoh Pharmaceutical rose 1.07%, with a transaction volume of HKD 229 million; Heng Rui Medicine rose 0.56%, with a market value of HKD 477.2 billion

    HK Stock Movers Tracker·
    HK
    01889
    +5.66%
    HK Stock Movers Tracker·
    HK
    01889
    +5.66%

    SANAI HEALTH GP released its interim results, with a loss attributable to shareholders of 10.861 million yuan, turning from profit to loss year-on-year

    According to the Zhitong Finance APP, SANAI HEALTH GP released its interim results for the six months ending June 30, 2025, reporting revenue of 47.222 million yuan, an increase of 28.57% year-on-year; the loss attributable to shareholders was 10.861 million yuan, compared to a profit of 9.971 million yuan in the same period last year; the loss per share was 0.071 yuan. The announcement stated that the increase in revenue was mainly due to the increase in revenue from the sale of pharmaceutical products by Beijing Hangyang during this period

    Zhitong·
    HK
    01889
    +5.66%
    Zhitong·
    HK
    01889
    +5.66%

    SANAI HEALTH GP issued a profit warning, expecting a mid-term loss attributable to shareholders of approximately 11.5 million to 14 million yuan

    SANAI HEALTH GP issued a profit warning, expecting to incur a shareholder loss of approximately HKD 11.5 million to HKD 14 million for the six months ending June 30, 2025, a significant decrease from the attributable profit of HKD 9.8 million in the same period of 2024. The loss is mainly due to the inability to repeat the non-recurring income of approximately HKD 17.04 million obtained in the same period of 2024, as well as an increase in distribution costs and administrative expenses of approximately HKD 4.6 million during the current period

    Zhitong·
    HK
    01889
    +5.66%
    Zhitong·
    HK
    01889
    +5.66%

    SANAI HEALTH GP: Zhang Rongqing resigns as executive director

    According to the Zhitong Finance APP, SANAI HEALTH GP announced that Professor Zhang Rongqing has resigned as executive director to devote more time to his personal affairs, effective from June 26, 2025 (resignation)

    Zhitong·
    HK
    01889
    +5.66%
    Zhitong·
    HK
    01889
    +5.66%

    SANAI HEALTH GP: Chen Chengqing is no longer an executive director

    According to the Zhitong Finance APP, SANAI HEALTH GP announced that Mr. Chen Chengqing will no longer serve as an executive director from the conclusion of the shareholders' annual meeting. The board has proposed (i) to remove Zhang Rongqing from the position of executive director; and (ii) to convene a special shareholders' meeting in accordance with the bylaws to consider and, if deemed appropriate, approve the proposed removal

    Zhitong·
    HK
    01889
    +5.66%
    Zhitong·
    HK
    01889
    +5.66%
    © 2025 Longbridge｜Disclaimer